For Vax Providers, Flu Season Off to a Running Start
It’s flu season again, and more than 690,000 people in the U.S. have already been vaccinated, reports healthcare analytics service SDI.
Articles by vanderson
Shire, Acceleron to Collaborate on Treatments for Rare Muscle Diseases
Shire Pharmaceuticals has signed a $498 million collaboration agreement with Acceleron Pharma to develop and commercialize treatments for muscular and neuromuscular disorders.
Americans Open to Using Mobile Health Devices, Report Finds
Americans are willing to use mobile devices to let physicians track their health, according to a new report from PricewaterhouseCoopers.
ZymoGenetics Acquisition Highlights Competitive Hepatitis C Treatment Race
Bristol-Myers Squibb Company (BMS) announced Tuesday that it had signed an agreement to acquire biopharmaceutical company ZymoGenetics for approximately $885 million, or $9.75 per share in cash.
Guiding Life Sciences Companies Along the Path to Success
Operating for over 50 years, Safeguard Scientifics is a holding company that provides capital, as well as strategic, operational and management resources for technology and life sciences companies.
Giving the Cold Shoulder to Cardiac Arrest Complications
According to a recent Reuters article, a treatment known as therapeutic hypothermia is saving the lives of cardiac arrest patients in hospitals across the U.S.
Telcare: Diabetes Control for the Digital Age
Telcare, a Bethesda, Md.-based company focused on connecting patients with their doctors via wireless technology, has developed a wireless glucose meter that enables two-way communication between patient and caregiver.
NeoChord Device Could Herald New Approach to Mitral Valve Repair
Approximately 250,000 new diagnoses of MR are made each year, but only about 50,000 patients undergo surgery to fix the problem.
S.E.A. Medical Developing Next Generation Prototype for IV Error Prevention
A recent study commissioned by the Society of Actuaries and completed by Milliman, Inc., highlighted both the high personal and financial costs exacted by measurable medical errors.
Getting a Leg Up on Knee Cartilage Repair with ProChon Biotech
ProChon’s lead product is BioCart, a second-generation tissue regeneration implant for the treatment of joint cartilage defects and injuries.